A Study Evaluating the Safety of Escalating Doses of DLYE5953A in Patients With Refractory Solid Tumors
Clinical trial NCT02092792 · COMPLETED
Trial details
- NCT number
- NCT02092792
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-07-10
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.